212 POSTER A phase II study of the KIT inhibitor XL820 in...

212 POSTER A phase II study of the KIT inhibitor XL820 in patients with advanced gastrointestinal stromal tumors (GIST) resistant to or intolerant of imatinib and/or sunitinib

A.J. Wagner, S. Yazji, J.A. Morgan, E. Choy, S. George, M. Hohos, M. O'Mara, G.D. Demetri
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
6
Year:
2008
Language:
english
DOI:
10.1016/s1359-6349(08)72144-x
File:
PDF, 59 KB
english, 2008
Conversion to is in progress
Conversion to is failed